Looks like filing for bankruptcy have nothing to do with FDA decision.\
- Mallinckrodt crashed as much as 34% on Tuesday after the pharmaceutical company said it was exploring the possibility of filing for Chapter 11 bankruptcy due to a number of factors including litigation related to its sale of opioids.
- Mallinckrodt is in the midst of a $US1.6 billion settlement for its sale of opioids, and is also on the hook for a $US650 million bill to Medicaid related to its Acthar Gel product.
- “Looking ahead, we expect our current challenges to continue in the back half of the year,” CEO Mark Trudeau said.
- Mallinckrodt shares are down 58% year-to-date
banter and General Discussion, page-1339
-
- There are more pages in this discussion • 11,040 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.35 |
Change
0.020(1.50%) |
Mkt cap ! $1.541B | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.40 | $1.34 | $3.562M | 2.615M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | $1.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.36 | 17969 | 2 |
View Market Depth
| Last trade - 16.10pm 07/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |